Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teligent Inc (NASDAQ:TLGT)

8.34
Delayed Data
As of Jul 22
 +0.02 / +0.24%
Today’s Change
4.46
Today|||52-Week Range
9.18
-6.29%
Year-to-Date
SECTOR
Consumer Non-Durables
INDUSTRY
Household/Personal Care
MARKET CAP
$442.5M

Company Description

Teligent, Inc. develops, manufactures and markets topical formulations. The company sells generic topical pharmaceutical products under IGI label. It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets. The company's products are used in a wide range of applications from cosmetics and cosmeceuticals to the prescription treatment of conditions like dermatitis, psoriasis, and eczema. The company was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ.

Contact Information

Teligent, Inc.
105 Lincoln Avenue
Buena New Jersey 08310
P:(856) 697-1441
Investor Relations:
18566974389363

Employees

Shareholders

Other institutional47.78%
Mutual fund holders25.16%
Individual stakeholders0.58%

Top Executives

Jason Grenfell-GardnerPresident, Chief Executive Officer & Director
Sanjay SamudreOperations Director
Jenniffer L. CollinsCFO, Secretary & Head-Investor Relations
Stephen RichardsonChief Scientific Officer
Nadya LawrenceSenior Vice President-Technical Services